Funding
Series E · Healthtech

GT Medical Technologies raises $100m Series E for brain-tumor implants

Viking Global Investors, MVM Partners, Gilde Healthcare and other investors participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

GT Medical Technologies raised $100 million in Series E financing on June 9. Participants included Viking Global Investors, MVM Partners, Gilde Healthcare, Evidity Health Capital, Medtech Venture Partners and FemHealth Ventures. The company develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors.

Funding history

Series E · This round$100M

Sources

  1. GT Medical Technologiesprojectstartups.com
  2. prnewswire.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Fairy Devices

Tokyo company developing wearable devices and remote-assistance software for industrial field workers.

UndisclosedJICN equity investment · Oct 23, 2026

Related